Flight Of The Navigator: Bluebird bio's Andrew Obenshain

The gene therapy firm is transitioning to a commercial organization

 
• By Jo Shorthouse
  
Andrew Obenshain
• Source: bluebird bio
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from Outlook Archive

More from Outlook 2024